Surface Oncology

4 followers


Surface Oncology is developing next generation immunotherapies that target the immune-suppressive tumor microenvironment to attack cancer.

Industries

Headquarters

Stage

Employees

Links

Org chart

Robert Ross
CEO, Director

Robert Ross

Collapse
Alison O’Neill
Chief Medical Officer
Lisa Mcgrath
Chief People Officer
Shannon Rourke Devens
VP, Clinical Development Operations